# Healthcare M&A Precedent Transactions - Sourced Data

**Date**: October 30, 2025
**Purpose**: Document all precedent transaction multiples with sources

---

## ‚ö†Ô∏è KEY FINDING: Limited Public Data on Transaction Multiples

After extensive research, **specific transaction multiples (EV/EBITDA) are rarely disclosed publicly** for healthcare M&A deals. Most press releases report:
- Total deal value (enterprise value)
- Sometimes revenue
- **RARELY** EBITDA or the resulting multiple

---

## üü¢ VERIFIED HEALTHCARE M&A TRANSACTIONS

### 1. **LifePoint Health / RCCH Healthcare Partners** (Apollo)

| Item | Value | Source |
|------|-------|--------|
| **Date** | November 2018 | SEC 8-K filing, press releases |
| **Buyer** | RCCH Healthcare Partners (Apollo Global Management) | |
| **Target** | LifePoint Health (NASDAQ: LPNT) | |
| **Transaction Value** | $5.6 billion | Healthcare Finance News, Fierce Healthcare |
| **Structure** | Includes $2.9B debt & minority interest | |
| **Q3 2018 EBITDA** | $183.3M (normalized) | LifePoint Q3 2018 earnings |
| **Estimated Annual EBITDA** | ~$730-750M | Calculated from quarterly |
| **Implied EV/EBITDA** | **~7.5x** | Calculated |
| **Premium to Market** | 36% to July 20, 2018 closing price | |
| **Source URLs** | Healthcare Finance News, Fierce Healthcare, Business Wire |

**Notes**:
- One of the largest hospital M&A transactions in recent years
- LifePoint operated ~70 hospitals at the time
- Transaction completed, company now private
- **Multiple calculation**: $5.6B / $750M est. EBITDA ‚âà 7.5x

---

### 2. **Newport Healthcare** - Onex Partners Acquisition

| Item | Value | Source |
|------|-------|--------|
| **Date** | July 2021 | PE Hub, Behavioral Health Business |
| **Buyer** | Onex Partners V | |
| **Seller** | Carlyle Group | |
| **Target** | Newport Healthcare (adolescent behavioral health) | |
| **Transaction Value** | $1.3 billion | PE Hub, multiple sources |
| **Trailing EBITDA** | Low $70M range | Behavioral Health Business |
| **Projected 2021 EBITDA** | North of $80M | Behavioral Health Business |
| **Implied EV/EBITDA** | **16-18x** | Calculated ($1.3B / $70-80M) |
| **Source URLs** | pehub.com, bhbusiness.com |

**Notes**:
- **High multiple** reflects:
  - Adolescent behavioral health (premium sub-sector)
  - Rapid growth profile
  - Peak valuation environment (2021)
- **Not representative** of general hospital M&A
- Company experienced challenges in 2024-2025 (facility closures, layoffs)

---

### 3. **Springstone / Medical Properties Trust**

| Item | Value | Source |
|------|-------|--------|
| **Date** | June 2021 | MPW press release |
| **Buyer** | Medical Properties Trust (NYSE: MPW) | |
| **Seller** | Welsh, Carson, Anderson & Stowe | |
| **Target** | Springstone (18 behavioral health facilities) | |
| **Transaction Value** | $950 million | MPW press release |
| **Structure** | $760M facilities + $190M operating interests | |
| **EBITDA** | **NOT DISCLOSED** | ‚Äî |
| **Implied Multiple** | **CANNOT CALCULATE** | No EBITDA disclosed |
| **GAAP Yield** | Exceeding 9.0% | MPW disclosure |
| **Lease Coverage** | 1.75x | MPW disclosure (implies EBITDAR coverage) |
| **Source URLs** | medicalpropertiestrust.gcs-web.com, bhbusiness.com |

**Notes**:
- This was a **PropCo transaction** (real estate, not OpCo)
- Lease coverage of 1.75x tells us: EBITDAR / Rent = 1.75x
- Cannot calculate OpCo multiple without EBITDA disclosure

---

### 4. **‚ö†Ô∏è CORRECTING MY EARLIER ERRORS**

| Transaction I Claimed | Reality | Status |
|----------------------|---------|--------|
| "Springstone / KKR (2021)" | **WRONG**: It was MPW, not KKR | ‚ùå Incorrect |
| "Newport Healthcare / GTCR (2023)" | **WRONG**: It was Onex / Carlyle (2021), not GTCR | ‚ùå Incorrect |
| "Regional Care / LifePoint (2022)" | **WRONG**: LifePoint/RCCH was 2018, no "Regional Care" deal in 2022 | ‚ùå Incorrect |

**I apologize** - these were placeholders based on general market knowledge, **NOT actual sourced transactions**.

---

## üü° INDUSTRY-LEVEL M&A MULTIPLE DATA (2023-2025)

Since specific hospital transactions with disclosed multiples are rare, here's what we know about **aggregate market data**:

### Hospital Systems (2023-2025)

| Source | Metric | Value | Date |
|--------|--------|-------|------|
| **First Page Sage** | Hospital EV/EBITDA | **7-9x** | 2025 report |
| **Healthcare Capital** | Healthcare services median | **10x EBITDA** | 2023 review |
| **Healthcare Capital** | 25th-75th percentile range | **7.2x - 13.9x** | 2023 review |
| **RL Hulett** | Strategic deals median (Q1 2025) | **8.0x EBITDA** | Q1 2025 report |
| **RL Hulett** | PE deals median (Q1 2025) | **18.3x EBITDA** | Q1 2025 report |

**Source URLs**:
- First Page Sage: firstpagesage.com/business/healthcare-ebitda-valuation-multiples/
- Healthcare Capital: healthcapital.com (2024 M&A report)
- RL Hulett: rlhulett.com (Q1 2025 M&A update)

---

### By Healthcare Sub-Sector (2023-2025)

| Sub-Sector | EV/EBITDA Range | Source | Notes |
|-----------|----------------|--------|-------|
| **Hospitals** | **7-9x** | First Page Sage, Buckhead FMV | Lower due to capex intensity |
| **Ambulatory Surgery Centers** | **9-13x** | Buckhead FMV | Higher than hospitals |
| **Physician Practices (large platforms)** | **10-12x** | Buckhead FMV | With integrated tech/RCM |
| **Physician Practices (small, single-specialty)** | **6-9x** | Buckhead FMV | Less scale |
| **Healthcare Services w/ Technology** | **7-15x** | Jahani & Associates | Depends on tech integration |
| **HealthTech** | **10-12.5x** | Healthcare.digital (April 2024) | Higher multiples for software |

---

## üìä WHAT THIS MEANS FOR UHS

### Conservative M&A Valuation (8x EBITDA)

```
UHS 2024 EBITDA:        $2,775M
√ó Conservative M&A:     8.0x
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Enterprise Value:       $22,205M
Less: Net Debt:         ($4,379M)
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Equity Value:           $17,826M
√∑ Shares:               63.64M
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Value per Share:        $280
```

### Base M&A Valuation (10x EBITDA)

```
UHS 2024 EBITDA:        $2,775M
√ó Base M&A:             10.0x (industry median)
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Enterprise Value:       $27,756M
Less: Net Debt:         ($4,379M)
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Equity Value:           $23,377M
√∑ Shares:               63.64M
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Value per Share:        $367
```

### Premium M&A Valuation (12x EBITDA)

```
UHS 2024 EBITDA:        $2,775M
√ó Premium M&A:          12.0x
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Enterprise Value:       $33,307M
Less: Net Debt:         ($4,379M)
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Equity Value:           $28,928M
√∑ Shares:               63.64M
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
Value per Share:        $455
```

---

## üéØ ADJUSTED FOOTBALL FIELD PRECEDENT TRANSACTIONS

### Old (Unsourced): $270 - $350 - $430

### New (Sourced from Industry Data):

| Case | Multiple | Value per Share | Rationale |
|------|----------|-----------------|-----------|
| **Low** | 8.0x | **$280** | Hospital-focused (lower end of 7-9x range) |
| **Base** | 10.0x | **$367** | Industry median for healthcare services |
| **High** | 12.0x | **$455** | Premium deal with behavioral health specialization |

**Sources**:
- 8x: First Page Sage (hospital range 7-9x)
- 10x: Healthcare Capital (2023 median for healthcare services)
- 12x: Upper range from 7.2-13.9x (75th percentile) + behavioral premium

---

## ‚ö†Ô∏è KEY LIMITATIONS

### What We CANNOT Say:

‚ùå "Springstone was acquired by KKR at 10x" - WRONG acquirer, no multiple disclosed
‚ùå "Newport Healthcare / GTCR at 10.7x" - WRONG buyer (Onex), WRONG year (2021 not 2023), and multiple was 16-18x not 10.7x
‚ùå "Regional Care / LifePoint at 7.2x" - No such transaction

### What We CAN Say:

‚úÖ "Hospital M&A typically trades at 7-9x EBITDA based on 2023-2025 market data (First Page Sage, 2025)"
‚úÖ "Healthcare services M&A median is 10x EBITDA (Healthcare Capital, 2023)"
‚úÖ "Strategic buyers paid median 8.0x in Q1 2025 (RL Hulett Q1 2025 report)"
‚úÖ "LifePoint/RCCH transaction in 2018 implied ~7.5x EBITDA based on disclosed financials"

---

## üìã REVISED RECOMMENDATION FOR FOOTBALL FIELD

### Precedent Transactions Row (15% Weight):

| Metric | Value | Source |
|--------|-------|--------|
| **Low** | $280 | 8.0x EBITDA (hospital-focused deal) |
| **Base** | $367 | 10.0x EBITDA (industry median) |
| **High** | $455 | 12.0x EBITDA (premium/behavioral specialty) |

### Disclosure Note for Presentation:

> "Precedent transaction multiples are based on aggregate market data for healthcare M&A (2023-2025) from industry reports (First Page Sage, Healthcare Capital, RL Hulett). Specific transaction multiples for comparable hospital deals are rarely publicly disclosed. Range reflects hospital M&A at 7-9x (low end) to healthcare services with specialized assets at 10-13x (high end)."

---

## üìö COMPLETE SOURCE BIBLIOGRAPHY

### Industry Reports

1. **First Page Sage** (2025): "Healthcare EBITDA & Valuation Multiples: 2025 Report"
   - URL: https://firstpagesage.com/business/healthcare-ebitda-valuation-multiples/
   - Data: Hospital EV/EBITDA 7-9x

2. **Healthcare Capital** (2023): "Healthcare Services M&A Transactions and Valuations"
   - URL: https://healthcapital.com (2024 M&A newsletter)
   - Data: Median 10x EBITDA, range 7.2x-13.9x (25th-75th percentile)

3. **Buckhead FMV** (2024): "Healthcare Services M&A: EBITDA Multiple Trends"
   - URL: https://www.buckheadfmv.com
   - Data: ASCs 9-13x, Physician practices 6-12x

4. **RL Hulett** (Q1 2025): "Healthcare M&A Update Q1 2025"
   - URL: https://rlhulett.com/app/uploads/2025/04/Healthcare-MA-Update-Q1-2025.pdf
   - Data: Strategic deals 8.0x, PE deals 18.3x median

5. **Jahani & Associates** (2024): "Healthcare Services Technology M&A Transactions and Valuations"
   - URL: https://jahaniandassociates.com
   - Data: 7-15x range depending on technology integration

### Specific Transactions

6. **LifePoint Health / RCCH** (2018):
   - Healthcare Finance News: "Apollo-owned RCCH HealthCare to acquire LifePoint Health in $5.6 billion merger"
   - URL: https://www.healthcarefinancenews.com
   - Business Wire: LifePoint Q3 2018 earnings
   - SEC 8-K filing: November 2018

7. **Newport Healthcare / Onex** (2021):
   - PE Hub: "Onex completes Newport Healthcare buy at $1.3bn value"
   - URL: https://www.pehub.com
   - Behavioral Health Business: "Onex Partners Finalizes 60% Purchase"

8. **Springstone / Medical Properties Trust** (2021):
   - MPW Press Release: June 2021
   - URL: https://medicalpropertiestrust.gcs-web.com
   - Behavioral Health Business: Transaction coverage

---

## ‚úÖ STATUS

**Precedent Transactions**:
- ‚úÖ Industry-level data VERIFIED (7-12x range)
- ‚úÖ LifePoint transaction VERIFIED (~7.5x calculated)
- ‚úÖ Newport transaction VERIFIED (16-18x, but not comparable to hospitals)
- ‚úÖ Springstone transaction VERIFIED (but PropCo, no multiple)
- ‚ùå No other directly comparable hospital M&A with disclosed multiples found

**Recommendation**: Use **industry aggregate data** (8-12x range) rather than claiming specific precedent transactions that cannot be verified.

**Updated Football Field Precedent Transactions**: $280 (low) - $367 (base) - $455 (high)
